Literature DB >> 26926634

Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections.

Samantha J Eells1, Megan Nguyen2, Jina Jung3, Raul Macias-Gil4, Larissa May5, Loren G Miller6.   

Abstract

Skin and soft tissue infections are common and frequently recur. Poor adherence to antibiotic therapy may lead to suboptimal clinical outcomes. However, adherence to oral antibiotic therapy for skin and soft tissue infections and its relationship to clinical outcomes have not been examined. We enrolled adult patients hospitalized with uncomplicated skin and soft tissue infections caused by Staphylococcus aureus who were being discharged with oral antibiotics to complete therapy. We fit the participants' pill bottles with an electronic bottle cap that recorded each pill bottle opening, administered an in-person standardized questionnaire at enrollment, 14 days, and 30 days, and reviewed the participants' medical records to determine outcomes. Our primary outcome was poor clinical response, defined as a change in antibiotic therapy, new incision-and-drainage procedure, or new skin infection within 30 days of hospital discharge. Of our 188 participants, 87 had complete data available for analysis. Among these participants, 40 (46%) had a poor clinical response at 30 days. The mean electronically measured adherence to antibiotic therapy was significantly different than the self-reported adherence (57% versus 96%; P < 0.0001). In a multivariable model, poor clinical response at 30 days was associated with patients having lower adherence, being nondiabetic, and reporting a lack of illicit drug use within the previous 12 months (P < 0.05). In conclusion, we found that patient adherence to oral antibiotic therapy for a skin and soft tissue infection after hospital discharge was low (57%) and associated with poor clinical outcome. Patients commonly overstate their medication adherence, which may make identification of patients at risk for nonadherence and poor outcomes challenging. Further studies are needed to improve postdischarge antibiotic adherence after skin and soft tissue infections.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26926634      PMCID: PMC4862485          DOI: 10.1128/AAC.02626-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Measuring adherence to antiretroviral medications in clinical trials.

Authors:  L G Miller; R D Hays
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

2.  Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic.

Authors:  Christopher J Graber; Mark A Jacobson; Francoise Perdreau-Remington; Henry F Chambers; Binh An Diep
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

3.  A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection.

Authors:  Loren G Miller; Clifford Quan; Anthony Shay; Katayoun Mostafaie; Kiran Bharadwa; Nelly Tan; Kelli Matayoshi; Jason Cronin; Jennifer Tan; Grace Tagudar; Arnold S Bayer
Journal:  Clin Infect Dis       Date:  2007-01-12       Impact factor: 9.079

4.  Prescriber continuity and medication adherence for complex patients.

Authors:  Richard A Hansen; Corrine I Voils; Joel F Farley; Benjamin J Powers; Linda L Sanders; Betsy Sleath; Matthew L Maciejewski
Journal:  Ann Pharmacother       Date:  2014-12-30       Impact factor: 3.154

5.  A comparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains.

Authors:  S J Eells; J A McKinnell; A A Wang; N L Green; D Whang; P O'Hara; M L Brown; L G Miller
Journal:  Epidemiol Infect       Date:  2012-12-06       Impact factor: 2.451

6.  Non-adherence to antibiotic therapy in patients visiting community pharmacies.

Authors:  Milene Fernandes; Andreia Leite; Maria Basto; Miguel Araújo Nobre; Nuno Vieira; Rui Fernandes; Paulo Nogueira; Paulo Jorge Nicola; Paulo Jorge
Journal:  Int J Clin Pharm       Date:  2013-10-08

7.  The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance.

Authors:  Carl Llor; Nuria Sierra; Silvia Hernández; Ana Moragas; Marta Hernández; Carolina Bayona; Marc Miravitlles
Journal:  J Antimicrob Chemother       Date:  2008-11-16       Impact factor: 5.790

8.  A study of adherence to antibiotic treatment in ambulatory respiratory infections.

Authors:  Carl Llor; Silvia Hernández; Carolina Bayona; Ana Moragas; Nuria Sierra; Marta Hernández; Marc Miravitlles
Journal:  Int J Infect Dis       Date:  2012-10-29       Impact factor: 3.623

Review 9.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

10.  A randomized, controlled study of an educational intervention to improve recall of auxiliary medication labeling and adherence to antibiotics.

Authors:  Jade A Pham; William Pierce; Lawrence Muhlbaier
Journal:  SAGE Open Med       Date:  2013-06-25
View more
  18 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

2.  Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Authors:  L Morata; J Cobo; M Fernández-Sampedro; P Guisado Vasco; E Ruano; J Lora-Tamayo; M Sánchez Somolinos; P González Ruano; A Rico Nieto; A Arnaiz; M Estébanez Muñoz; M E Jiménez-Mejías; A B Lozano Serrano; E Múñez; D Rodriguez-Pardo; R Argelich; A Arroyo; J M Barbero; F Cuadra; A Del Arco; M D Del Toro; L Guio; D Jimenez-Beatty; N Lois; O Martin; R M Martínez Alvarez; F J Martinez-Marcos; L Porras; M Ramírez; J Vergas García; A Soriano
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.

Authors:  G Ralph Corey; Jeffery Loutit; Greg Moeck; Matthew Wikler; Michael N Dudley; William O'Riordan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants.

Authors:  Anika Shakil; Faye Y Hern; Chung Liu; Kartik Temburnikar; Pierre Chambon; Neill Liptrott; Tom O McDonald; Megan Neary; Andrew Owen; Caren Freel Meyers; Steve P Rannard
Journal:  J Mater Chem B       Date:  2022-06-15       Impact factor: 7.571

5.  Taste Perceptions of Common Pediatric Antibiotic Suspensions and Associated Prescribing Patterns in Medical Residents.

Authors:  Neelkamal Soares; Rachel Mitchell; Theresa McGoff; Teresa Bailey; Gregory S Wellman
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09

Review 6.  Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review.

Authors:  Jason P Burnham; John P Kirby; Marin H Kollef
Journal:  Intensive Care Med       Date:  2016-10-03       Impact factor: 17.440

7.  Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States.

Authors:  Jonathan D Alpern; Lei Zhang; William M Stauffer; Aaron S Kesselheim
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

8.  A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program.

Authors:  Mark Redell; Greg Moeck; Christopher Lucasti; Stephanie Durso; Cynthia Kennedy; Karen Fusaro; Jeff Loutit; Michael Dudley
Journal:  Open Forum Infect Dis       Date:  2018-03-19       Impact factor: 3.835

9.  Perspectives of Patients on Outpatient Parenteral Antimicrobial Therapy: Experiences and Adherence.

Authors:  Yasir Hamad; Sai Dodda; Allison Frank; Joe Beggs; Christopher Sleckman; Glen Kleinschmidt; Michael A Lane; Yvonne Burnett
Journal:  Open Forum Infect Dis       Date:  2020-06-02       Impact factor: 3.835

10.  Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education.

Authors:  Safa S Almarzoky Abuhussain; Michelle A Burak; Danyel K Adams; Kelsey N Kohman; Serina B Tart; Athena L V Hobbs; Gabrielle Jacknin; Michael D Nailor; Katelyn R Keyloun; David P Nicolau; Joseph L Kuti
Journal:  Open Forum Infect Dis       Date:  2018-10-08       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.